Quantitative Investment Management, LLC
Position in INSM — INSMED Inc
CIK 1445911
CHARLOTTESVILLE, VA
Position in INSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,694,618
-$644,535 QoQ
Shares Held
15,894
+11.1% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#298
of 663 holders
Holding Since
Mar 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Quantitative Investment Management, LLC holds $20,430,992 across 8 Biotechnology names. INSM ranks #4 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
13,499 | $8,417,166 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,342 | $4,143,721 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7,981 | $2,402,520 | |
| 4 | INSM |
INSMED Inc
This page
|
15,894 | $1,694,618 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
41,416 | $1,615,638 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
16,631 | $1,301,708 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,985 | $529,439 | |
| 8 | RXRX |
Recursion Pharmaceuticals, Inc.
|
88,878 | $326,182 |
All Filings in INSM
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,694,618 | 15,894 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,339,153 | 14,305 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,418,077 | 8,148 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $1,269,573 | 12,615 | Shares | Sole | 2025-08-14 | |
| 2020-12-31 | $306,467 | 9,206 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,204,285 | 37,470 | Shares | Sole | 2020-11-13 | |
| 2020-03-31 | $667,152 | 41,619 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||